Frankfurt - Delayed Quote EUR
Spero Therapeutics, Inc. (2HA.F)
0.5890
-0.0450
(-7.10%)
As of 9:59:01 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
27,396
27,396
96,735
48,579
3,070
Operating Expense
99,880
99,880
69,948
79,146
91,041
Operating Income
-72,484
-72,484
26,787
-30,567
-87,971
Net Non Operating Interest Income Expense
4,735
4,735
3,937
-1,499
-1,594
Other Income Expense
-817
-817
-5,320
-14,349
-191
Pretax Income
-68,566
-68,566
25,404
-46,415
-89,756
Tax Provision
--
--
2,598
--
--
Net Income Common Stockholders
-68,566
-68,566
22,806
-46,415
-89,756
Diluted NI Available to Com Stockholders
-68,566
-68,566
22,806
-46,415
-89,756
Basic EPS
0.08
-1.27
0.43
-1.23
-2.91
Diluted EPS
0.08
-1.27
0.43
-1.23
-2.91
Basic Average Shares
53,653.0530
54,037.9170
52,703.4670
37,585.0750
30,895.7560
Diluted Average Shares
53,938.6160
54,037.9170
52,989.0300
37,585.0750
30,895.7560
Total Operating Income as Reported
-73,361
-73,361
21,481
-42,197
-87,971
Total Expenses
99,880
99,880
69,948
79,146
91,041
Net Income from Continuing & Discontinued Operation
-68,566
-68,566
22,806
-46,415
-89,756
Normalized Income
-67,689
-67,689
27,569.3694
-35,702
-89,960
Interest Income
4,735
4,735
3,937
1,106
346
Interest Expense
4,545
--
--
2,605
1,940
Net Interest Income
4,735
4,735
3,937
-1,499
-1,594
EBIT
-72,484
-72,484
26,787
-43,810
-87,816
EBITDA
-72,482
-72,482
27,154
-42,941
-87,170
Reconciled Depreciation
2
2
367
869
646
Net Income from Continuing Operation Net Minority Interest
-68,566
-68,566
22,806
-46,415
-89,756
Total Unusual Items Excluding Goodwill
-877
-877
-5,306
-10,713
204
Total Unusual Items
-877
-877
-5,306
-10,713
204
Normalized EBITDA
-71,605
-71,605
32,460
-32,228
-87,374
Tax Rate for Calcs
--
--
0.0001
--
--
Tax Effect of Unusual Items
--
--
-542.6306
--
--
12/31/2021 - 5/7/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RPD.MU Royalty Pharma plc
28.09
-0.92%
05Y.MU Vivoryon Therapeutics NV
1.8320
+2.46%
P0F.F Egetis Therapeutics AB (publ)
0.3310
+14.14%
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%
MVR0.BE Medivir AB
0.1238
-7.61%
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
ARDX.MX Ardelyx, Inc.
105.50
0.00%
PI3.DU Gubra AS
46.92
-2.70%
ICY.HA Incyte Corp
50.76
-0.43%
PROT Proteonomix, Inc.
0.0000
0.00%